Literature DB >> 18373173

Chromoendoscopy with hematoxylin in the classification of gastric lesions.

Serguei Mouzyka1, Alexandra Fedoseeva.   

Abstract

BACKGROUND: Hematoxylin is a basic histological stain which stains nuclei. Apparently, it can be used with endoscopy to diagnose malignant lesions due to their increased nucleus-tocytoplasm ratio. The aim of this study was to evaluate the use of hematoxylin in the differentiation of gastric lesions.
METHODS: Part 1. In a prospective study, a total of 70 different gastric abnormalities were stained with 1% hematoxylin solution during upper endoscopy. Results of histological examinations were compared with endoscopic findings. Part 2. During a 5-day period, antral mucosa was stained with hematoxylin in all patients (n = 26), independent of the upper endoscopy results. Grades of stained mucosa were compared with the proliferating cell nuclear antigen (PCNA) index, which was examined using an immunohistochemical method. Part 3. Gastric biopsies (total, 12) were obtained from the stained and unstained areas within the limits of one lesion (total, 6) after chromoscopy with hematoxylin and examined with monoclonal (PCNA) antibodies.
RESULTS: Using histological findings, the sensitivity and specificity of chromoendoscopy with hematoxylin for detecting gastric neoplasia and adenocarcinoma were determined. A significant positive correlation (r = 0.81; P < 0.001) was found between the PCNA index and grade of endoscopic stained mucosa. The PCNA index was increased in stained areas of gastric abnormalities in comparison to unstained areas within the limits of one lesion in all six patients.
CONCLUSION: Chromoendoscopy with hematoxylin increases opportunities for precision biopsy. The grade of endoscopic stained mucosa depends on epithelial cell proliferation and is associated with malignancy. By using histology as the main outcome, the sensitivity and specificity of chromoendoscopy with hematoxylin for diffuse staining in the detection of gastric neoplasia and adenocarcinoma were 92.9% and 89.3%, respectively.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18373173     DOI: 10.1007/s10120-007-0445-4

Source DB:  PubMed          Journal:  Gastric Cancer        ISSN: 1436-3291            Impact factor:   7.370


  3 in total

1.  Methylene blue but not indigo carmine causes DNA damage to colonocytes in vitro and in vivo at concentrations used in clinical chromoendoscopy.

Authors:  J Davies; D Burke; J R Olliver; L J Hardie; C P Wild; M N Routledge
Journal:  Gut       Date:  2007-01       Impact factor: 23.059

Review 2.  Chromoendoscopy.

Authors:  Louis Michel Wong Kee Song; Douglas G Adler; Bipan Chand; Jason D Conway; Joseph M B Croffie; James A Disario; Daniel S Mishkin; Raj J Shah; Lehel Somogyi; William M Tierney; Bret T Petersen
Journal:  Gastrointest Endosc       Date:  2007-07-23       Impact factor: 9.427

3.  Chromoendoscopy with hematoxylin in the classification of gastric lesions.

Authors:  Serguei Mouzyka; Alexandra Fedoseeva
Journal:  Gastric Cancer       Date:  2008-03-29       Impact factor: 7.370

  3 in total
  7 in total

1.  Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED).

Authors:  M Dinis-Ribeiro; M Areia; A C de Vries; R Marcos-Pinto; M Monteiro-Soares; A O'Connor; C Pereira; P Pimentel-Nunes; R Correia; A Ensari; J M Dumonceau; J C Machado; G Macedo; P Malfertheiner; T Matysiak-Budnik; F Megraud; K Miki; C O'Morain; R M Peek; T Ponchon; A Ristimaki; B Rembacken; F Carneiro; E J Kuipers
Journal:  Virchows Arch       Date:  2011-12-22       Impact factor: 4.064

2.  Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED).

Authors:  M Dinis-Ribeiro; M Areia; A C de Vries; R Marcos-Pinto; M Monteiro-Soares; A O'Connor; C Pereira; P Pimentel-Nunes; R Correia; A Ensari; J M Dumonceau; J C Machado; G Macedo; P Malfertheiner; T Matysiak-Budnik; F Megraud; K Miki; C O'Morain; R M Peek; T Ponchon; A Ristimaki; B Rembacken; F Carneiro; E J Kuipers
Journal:  Endoscopy       Date:  2011-12-23       Impact factor: 10.093

Review 3.  Screening for and surveillance of gastric cancer.

Authors:  Debora Compare; Alba Rocco; Gerardo Nardone
Journal:  World J Gastroenterol       Date:  2014-10-14       Impact factor: 5.742

4.  Narrow band imaging for the detection of gastric intestinal metaplasia and dysplasia during surveillance endoscopy.

Authors:  Lisette G Capelle; Jelle Haringsma; Annemarie C de Vries; Ewout W Steyerberg; Katharina Biermann; Herman van Dekken; Ernst J Kuipers
Journal:  Dig Dis Sci       Date:  2010-12       Impact factor: 3.199

5.  Chromoendoscopy with hematoxylin in the classification of gastric lesions.

Authors:  Serguei Mouzyka; Alexandra Fedoseeva
Journal:  Gastric Cancer       Date:  2008-03-29       Impact factor: 7.370

Review 6.  Evidence based review of the impact of image enhanced endoscopy in the diagnosis of gastric disorders.

Authors:  Ikram Hussain; Tiing Leong Ang
Journal:  World J Gastrointest Endosc       Date:  2016-12-16

7.  Advanced endoscopic imaging in gastric neoplasia and preneoplasia.

Authors:  Jonathan W J Lee; Lee Guan Lim; Khay Guan Yeoh
Journal:  BMJ Open Gastroenterol       Date:  2017-01-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.